TY - JOUR
T1 - Biphasic dopamine regulation in mesoaccumbens pathway in response to non-contingent binge and escalating methamphetamine regimens in the Wistar rat
AU - Keller, Courtney M.
AU - Salvatore, Michael F.
AU - Pruett, Brandon S.
AU - Guerin, Glenn F.
AU - Goeders, Nicholas E.
N1 - Funding Information:
Acknowledgments We thank Clint Kinney, Sandy Spann, Victoria Fields, and Charles Dempsey for their diligent technical work in the project. This work was supported in part by USPSH grant DA06013 from the National Institute on Drug Abuse.
Copyright:
Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2011/6
Y1 - 2011/6
N2 - Rationale Methamphetamine (MA) increases extracellular dopamine (DA) and at chronic high doses induces toxicity as indicated by decreased expression of tyrosine hydroxylase (TH) and dopamine transporter (DAT). Notably, rats will self-administer MA in escalating quantities producing such toxicity. However, the impact of MA at sub-toxic doses on DA regulation is not well established. Objective The temporal dynamics of DA regulation following cessation of sub-toxic escalating and binge doses of non-contingent MA were investigated as changes therein may be associated with escalation of MA intake. Materials and methods MA was administered 3×/day using an established 14-day escalating-dose regimen (0.1-4.0mg/kg) or a single-day binge-style administration (3×4 mg/kg). DA tissue content, DA turnover, TH protein, TH phosphorylation, DAT, and vesicular monoamine transporter 2 were measured in nigrostriatal and mesoaccumbens pathways 48 h and 2 weeks after MA cessation. Results Changes in striatal DA regulation were limited to increased DA turnover. However, in the mesoaccumbens pathway, escalating MA had biphasic effects. DA was increased in ventral tegmental area (VTA) and decreased in nucleus accumbens at 48 h post-MA while the reverse was seen at 2 weeks. These changes were matched by similar changes in TH protein and, in the VTA, by changes in DAT. Conclusion Escalation of MA intake produces both transient and long-lasting effects upon DA, TH, and DAT in the mesoaccumbens pathway. The eventual decrease of DA in the VTA is speculated to contribute to craving for MA and, thus, may be associated with MA escalation and resulting dopaminergic toxicity.
AB - Rationale Methamphetamine (MA) increases extracellular dopamine (DA) and at chronic high doses induces toxicity as indicated by decreased expression of tyrosine hydroxylase (TH) and dopamine transporter (DAT). Notably, rats will self-administer MA in escalating quantities producing such toxicity. However, the impact of MA at sub-toxic doses on DA regulation is not well established. Objective The temporal dynamics of DA regulation following cessation of sub-toxic escalating and binge doses of non-contingent MA were investigated as changes therein may be associated with escalation of MA intake. Materials and methods MA was administered 3×/day using an established 14-day escalating-dose regimen (0.1-4.0mg/kg) or a single-day binge-style administration (3×4 mg/kg). DA tissue content, DA turnover, TH protein, TH phosphorylation, DAT, and vesicular monoamine transporter 2 were measured in nigrostriatal and mesoaccumbens pathways 48 h and 2 weeks after MA cessation. Results Changes in striatal DA regulation were limited to increased DA turnover. However, in the mesoaccumbens pathway, escalating MA had biphasic effects. DA was increased in ventral tegmental area (VTA) and decreased in nucleus accumbens at 48 h post-MA while the reverse was seen at 2 weeks. These changes were matched by similar changes in TH protein and, in the VTA, by changes in DAT. Conclusion Escalation of MA intake produces both transient and long-lasting effects upon DA, TH, and DAT in the mesoaccumbens pathway. The eventual decrease of DA in the VTA is speculated to contribute to craving for MA and, thus, may be associated with MA escalation and resulting dopaminergic toxicity.
KW - Dopamine
KW - Dopamine transporter
KW - Methamphetamine
KW - Nigrostriatal
KW - Nucleus accumbens
KW - Signal transduction
KW - Striatum
KW - Substantia nigra
KW - Tyrosine hydroxylase
KW - Ventral tegmental area
KW - Vesicular monoamine transporter
UR - http://www.scopus.com/inward/record.url?scp=80052345891&partnerID=8YFLogxK
U2 - 10.1007/s00213-011-2301-9
DO - 10.1007/s00213-011-2301-9
M3 - Article
C2 - 21523347
AN - SCOPUS:80052345891
SN - 0033-3158
VL - 215
SP - 513
EP - 526
JO - Psychopharmacologia
JF - Psychopharmacologia
IS - 3
ER -